Friday, January 26, 2024
The purpose of this transmittal is to notify DC Medicaid Providers of a policy change regarding reimbursement rates for physician-administered drugs under the "Buy & Bill" policy. The Centers for Medicare and Medicaid Services (CMS) recently approved an update to the District of Columbia (DC) Medicaid State Plan. The State Plan Amendment allows the Department of Health Care Finance (DHCF) to modify the reimbursement methodology for physician-administered drugs.